NCT02544113View on ClinicalTrials.gov

A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 26, 2018

Study Completion Date

January 3, 2020

Conditions
Liver Failure
Interventions
DRUG

Thymoglobulin

Treatment with thymoglobulin and delayed CNI post OLT

DRUG

Placebo

Normal transplant immunosuppression

Trial Locations (4)

33331

Cleveland Clinic Florida, Weston

44195

Cleveland Clinic (Main Campus), Cleveland

53226

Medical College of Wisconsin, Milwaukee

Unknown

University of Cincinnati College of Medicine, Cincinnati

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT02544113 - A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver Transplantation | Biotech Hunter | Biotech Hunter